X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10441) 10441
Newspaper Article (460) 460
Newsletter (269) 269
Book Chapter (68) 68
Magazine Article (32) 32
Book / eBook (17) 17
Publication (9) 9
Dissertation (5) 5
Reference (4) 4
Transcript (4) 4
Trade Publication Article (3) 3
Conference Proceeding (2) 2
Report (2) 2
Book Review (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7546) 7546
anticoagulants (5721) 5721
male (3433) 3433
female (3073) 3073
anticoagulants - therapeutic use (2887) 2887
warfarin (2850) 2850
anticoagulants - administration & dosage (2610) 2610
pharmacology & pharmacy (2414) 2414
anticoagulants - adverse effects (2066) 2066
aged (2030) 2030
middle aged (2007) 2007
hematology (2001) 2001
anticoagulants - pharmacokinetics (1893) 1893
pharmacokinetics (1756) 1756
adult (1573) 1573
thromboembolism (1498) 1498
peripheral vascular disease (1486) 1486
administration, oral (1478) 1478
animals (1470) 1470
rivaroxaban (1423) 1423
thrombosis (1423) 1423
venous thromboembolism (1389) 1389
anticoagulants - pharmacology (1370) 1370
dabigatran (1308) 1308
atrial fibrillation (1275) 1275
prevention (1267) 1267
stroke (1203) 1203
heparin (1199) 1199
risk factors (1193) 1193
anticoagulation (1155) 1155
cardiac & cardiovascular systems (1081) 1081
drug therapy (1075) 1075
hemorrhage - chemically induced (1018) 1018
treatment outcome (1005) 1005
drug interactions (976) 976
dose-response relationship, drug (973) 973
molecular-weight heparin (951) 951
thrombin (951) 951
analysis (945) 945
medicine & public health (940) 940
research (919) 919
blood coagulation - drug effects (911) 911
aged, 80 and over (905) 905
therapy (896) 896
warfarin - administration & dosage (837) 837
care and treatment (826) 826
international normalized ratio (826) 826
patients (824) 824
pharmacodynamics (804) 804
atrial-fibrillation (797) 797
apixaban (776) 776
factor xa inhibitors (766) 766
warfarin - therapeutic use (760) 760
enoxaparin (757) 757
atrial fibrillation - drug therapy (755) 755
dosage and administration (728) 728
risk (721) 721
health aspects (720) 720
drug dosages (702) 702
warfarin - pharmacokinetics (686) 686
anticoagulant (684) 684
surgery (684) 684
safety (673) 673
management (669) 669
unfractionated heparin (665) 665
bleeding (664) 664
cardiology (659) 659
medicine, general & internal (645) 645
cardiac arrhythmia (637) 637
clinical trials (625) 625
warfarin - adverse effects (618) 618
pharmacology (607) 607
stroke - prevention & control (601) 601
deep-vein thrombosis (590) 590
coagulation (574) 574
oral anticoagulants (574) 574
retrospective studies (555) 555
internal medicine (550) 550
time factors (543) 543
dabigatran etexilate (540) 540
thromboembolism - prevention & control (529) 529
atrial fibrillation - complications (519) 519
hemorrhage (517) 517
abridged index medicus (510) 510
rats (505) 505
heparin - therapeutic use (488) 488
mortality (488) 488
drugs (482) 482
antithrombotic therapy (472) 472
pharmacology/toxicology (462) 462
medical research (460) 460
metabolism (455) 455
pharmacogenetics (453) 453
usage (452) 452
heparin, low-molecular-weight - therapeutic use (440) 440
blood (438) 438
partial thromboplastin time (438) 438
prospective studies (436) 436
studies (436) 436
direct thrombin inhibitor (434) 434
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11050) 11050
German (140) 140
French (78) 78
Japanese (47) 47
Spanish (41) 41
Russian (39) 39
Italian (23) 23
Portuguese (17) 17
Chinese (11) 11
Czech (10) 10
Danish (7) 7
Polish (7) 7
Turkish (7) 7
Dutch (5) 5
Swedish (5) 5
Hungarian (4) 4
Bulgarian (2) 2
Finnish (2) 2
Korean (2) 2
Norwegian (2) 2
Serbian (2) 2
Slovenian (2) 2
Arabic (1) 1
Romanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial agents and chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 105 - 114
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 24, pp. 2888 - 2899
... dialysis. The authors review the current pharmacokinetic, observational, and prospective data on NOACs in patients with advanced chronic kidney disease... 
Cardiovascular | Internal Medicine | dabigatran | rivaroxaban | apixaban | stroke | edoxaban | renal dialysis | CARDIAC & CARDIOVASCULAR SYSTEMS | APPENDAGE CLOSURE | PLATELET-AGGREGATION | SAFETY | PHARMACOKINETICS | PROTHROMBIN COMPLEX CONCENTRATE | ORAL ANTICOAGULANTS | HEMODIALYSIS-PATIENTS | NONVALVULAR ATRIAL-FIBRILLATION | STAGE RENAL-DISEASE | WARFARIN USE | Pyrazoles - therapeutic use | Dabigatran - pharmacokinetics | Humans | Pyridines - pharmacokinetics | Renal Insufficiency, Chronic - complications | Thiazoles - therapeutic use | Dabigatran - therapeutic use | Thiazoles - pharmacokinetics | Warfarin - therapeutic use | Renal Insufficiency, Chronic - therapy | Kidney - metabolism | Pyrazoles - pharmacokinetics | Rivaroxaban - therapeutic use | Pyridines - therapeutic use | Stroke - prevention & control | Glomerular Filtration Rate | Pyridones - pharmacokinetics | Atrial Fibrillation - drug therapy | Anticoagulants - therapeutic use | Creatinine - urine | Warfarin - pharmacokinetics | Kidney Failure, Chronic - therapy | Rivaroxaban - pharmacokinetics | Kidney Failure, Chronic - complications | Anticoagulants - pharmacokinetics | Pyridones - therapeutic use | Hemorrhage - chemically induced | Renal Dialysis | Stroke (Disease) | Medical colleges | Care and treatment | Continuing medical education | Warfarin | Chronic kidney failure | Atrial fibrillation | Mortality | Medical care | Quality management | Urine | Confidence intervals | Disease prevention | Anticoagulants | Stroke | Hemodialysis | Kidney diseases | Metabolism | Drug dosages
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 2013, Volume 76, Issue 3, pp. 455 - 466
...) and breast cancer resistance protein (Bcrp) (ABCG2). Methods The pharmacokinetic effects of substrates or inhibitors of CYP3A4, P‐gp and Bcrp (ABCG2... 
P‐glycoprotein | rivaroxaban | drug interactions | cytochrome P450 | healthy subjects | P-glycoprotein | Rivaroxaban | Healthy subjects | Cytochrome P450 | Drug interactions | BAY-59-7939 | SAFETY | PREVENTION | PHARMACODYNAMICS | PROTEASE INHIBITORS | IN-VITRO | FACTOR-XA INHIBITOR | ERYTHROMYCIN | PHARMACOLOGY & PHARMACY | LIVER-MICROSOMES | Anticoagulants - administration & dosage | Cytochrome P-450 Enzyme Inhibitors | Erythromycin - pharmacology | Ketoconazole - administration & dosage | Humans | Middle Aged | Cytochrome P-450 Enzyme System - metabolism | Midazolam - administration & dosage | Substrate Specificity | Metabolic Clearance Rate | Thiophenes - administration & dosage | Ketoconazole - pharmacology | Enzyme Inhibitors - administration & dosage | Young Adult | Drug Interactions | Enzyme Inhibitors - pharmacokinetics | Clarithromycin - pharmacokinetics | Clarithromycin - administration & dosage | Adult | Morpholines - administration & dosage | Enzyme Inhibitors - pharmacology | Ketoconazole - pharmacokinetics | Midazolam - pharmacokinetics | Cytochrome P-450 CYP3A - administration & dosage | Erythromycin - administration & dosage | ATP Binding Cassette Transporter, Subfamily B, Member 1 - antagonists & inhibitors | ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism | Thiophenes - pharmacokinetics | Erythromycin - pharmacokinetics | Cytochrome P-450 CYP3A - metabolism | Adolescent | Anticoagulants - pharmacokinetics | Morpholines - pharmacokinetics | Clarithromycin - pharmacology | Midazolam - pharmacology | Ketoconazole | Protease inhibitors | Fluconazole | Proteases | Cytochrome P-450 | Dosage and administration | Anticoagulants (Medicine) | Erythromycin | Thromboembolism
Journal Article
Journal Article